1. Home
  2. FGEN vs ORIS Comparison

FGEN vs ORIS Comparison

Compare FGEN & ORIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • ORIS
  • Stock Information
  • Founded
  • FGEN 1993
  • ORIS 2014
  • Country
  • FGEN United States
  • ORIS China
  • Employees
  • FGEN N/A
  • ORIS N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • ORIS Farming/Seeds/Milling
  • Sector
  • FGEN Health Care
  • ORIS Consumer Staples
  • Exchange
  • FGEN Nasdaq
  • ORIS Nasdaq
  • Market Cap
  • FGEN 34.5M
  • ORIS 30.4M
  • IPO Year
  • FGEN 2014
  • ORIS 2024
  • Fundamental
  • Price
  • FGEN $0.46
  • ORIS $0.99
  • Analyst Decision
  • FGEN
  • ORIS
  • Analyst Count
  • FGEN 0
  • ORIS 0
  • Target Price
  • FGEN N/A
  • ORIS N/A
  • AVG Volume (30 Days)
  • FGEN 727.9K
  • ORIS 323.8K
  • Earning Date
  • FGEN 02-24-2025
  • ORIS 02-21-2025
  • Dividend Yield
  • FGEN N/A
  • ORIS N/A
  • EPS Growth
  • FGEN N/A
  • ORIS N/A
  • EPS
  • FGEN N/A
  • ORIS 0.43
  • Revenue
  • FGEN $180,015,000.00
  • ORIS $16,745,999.00
  • Revenue This Year
  • FGEN $21.91
  • ORIS N/A
  • Revenue Next Year
  • FGEN N/A
  • ORIS N/A
  • P/E Ratio
  • FGEN N/A
  • ORIS $2.30
  • Revenue Growth
  • FGEN 16.15
  • ORIS N/A
  • 52 Week Low
  • FGEN $0.18
  • ORIS $0.94
  • 52 Week High
  • FGEN $2.80
  • ORIS $56.01
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 41.72
  • ORIS N/A
  • Support Level
  • FGEN $0.46
  • ORIS N/A
  • Resistance Level
  • FGEN $0.51
  • ORIS N/A
  • Average True Range (ATR)
  • FGEN 0.04
  • ORIS 0.00
  • MACD
  • FGEN -0.01
  • ORIS 0.00
  • Stochastic Oscillator
  • FGEN 6.59
  • ORIS 0.00

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.

About ORIS Oriental Rise Holdings Limited Ordinary Shares

Oriental Rise Holdings Ltd is a company who is an integrated supplier of tea products in Mainland China. Their major tea products include primarily-processed tea consisting of white tea and black tea, and refined white tea and black tea. Its business operations are vertically integrated, covering cultivation, processing of tea leaves and the sale of tea products to tea business operators (such as wholesale distributors) and end-user retail customers in Mainland China.

Share on Social Networks: